Firefly Neuroscience jumps on U.S. military health partnership

Firefly Neuroscience

26/03/2026 12:47

** Shares of medtech firm Firefly Neuroscience AIFF.O rise 24.99% to $2.10 premarket

** Co says it has entered a partnership with the U.S. Department of War, tied to U.S. military health programs

** Says its FDA-cleared brain scan technology will be used to help assess and treat post-traumatic stress disorder and traumatic brain injury in active-duty service members and veterans

** Says the technology gives healthcare providers brain data to help with diagnosis, treatment planning and tracking patient progress

** Adds the partnership expands its commercial reach into the U.S. government and defense health sectors

** Specific details of the partnership and related programs remain confidential - AIFF

** AIFF shares were down over 66% in 2025

(Reporting by Kunal Das in Bengaluru)

((Kunal.Das2@thomsonreuters.com;))